Skip to main content

Table 3 Secondary outcomes

From: A pilot feasibility study of gabapentin for managing pain in children with dystonic cerebral palsy

Outcome measure BaselineMean (SD) 6 weeksMean (SD) 12 weeksMean (SD) Difference from baseline at 12 weeksMean 95 % (CI)
COPM performance 3.6 (0.9) N = 12 Not collected 7.0 (1.4) N = 11 3.5 (2.3, 4.6)
COPM satisfaction 2.2 (0.9) N = 12 Not collected 7.2 (2.6) N = 11 4.8 (3.1, 6.6)
BADS 23.8 (4.3) N = 12 20.9 (6.4) N = 10 21.9 (3.8) N = 10 -1.4 (-3.6, 0.8)
FPS-R 2.8 (1.4) N = 12 1.5 (1.3) N = 12 1.0 (1.3) N = 10 -1.8 (-3.1, -0.5)
CPCHILD
 Personal care 36.7 (20.3) N = 13 52.9 (22.3) N = 7 49.4 (18.2) N = 11 10.3 (2.0, 18.6)
 Positioning/transferring/mobility 38.8 (19.7) N = 13 53.0 (16.8) N = 7 51.4 (17.9) N = 11 8.3 (-4.9, 21.6)
 Comfort & emotions 62.4 (23.4) N = 13 78.9 (14.8) N = 7 81.2 (12.4) N = 11 11.1 (1.5, 20.8)
 Communication/social interaction 54.6 (17.0) N = 13 72.1 (16.7) N = 7 70.0 (14.3) N-11 13.0 (2.6, 23.4)
 Health 64.6 (17.7) N = 13 60.0 (13.9) N = 7 73.9 (11.7) N = 11 6.7 (-2.7, 16.1)
 Overall QoL 67.7 (27.7) N = 13 80.0 (17.9) N = 7 70.9 (16.4) N = 11 0.0 (-6.0, 6.0)
 Total 54.1 (16.6) N = 13 65.5 (14.0) N = 7 66.1 (11.7) N = 11 8.2 (0.9, 15.6)
CCHQ
 Personal care 4.1 (1.2) N = 13 2.6 (1.5) N = 6 3.2 (1.3) N = 11 -0.8 (-1.7, 0.10)
 Positioning/transferring 3.9 (1.6) N = 13 2.3 (1.3) N = 6 2.5 (1.1) N = 11 -1.1 (-2.2, -0.10)
Comfort 3.6 (1.2) N = 13 2.7 (1.4) N = 6 2.5 (1.5) N = 11 -0.9 (-1.6, -0.20)
 Interaction/communication 3.3 (1.1) N = 13 2.5 (0.9) N = 6 2.8 (1.1) N = 11 -0.5 (-0.9, -0.10)
  1. SD Standard Deviation, CI Confidence interval, COPM Canadian Occupational Performance Measure, BADS Barry Albright Dystonia Scale, FPS-R Face Pain Scale- revised, CPCHILD Caregiver Priorities & Child Health Index of Life with Disabilities, CCHQ Care and Comfort Hypertonicity Questionnaire